GlassScriptPhysician profile
Matthew C Murray
NPI 1629253844
$12,532.59
in general payments reported to CMS, 2019-2025
16 companies · $2,896 in 2025
The $2,896 reported for 2025 was more than what 76% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $690 · 2020: $1,330 · 2021: $59.83 · 2022: $4,244 · 2023: $762 · 2024: $2,550 · 2025: $2,896.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,067 · Food and Beverage: $2,141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,067.04 |
| Food and Beverage | $2,141.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $5,832.89 | 2019-2025 | Healicoil, Acufex Meniscal Root Repair, Novostitch |
| Arthrex, INC. | $2,856.17 | 2020-2024 | |
| Mission Medical Distribution, LLC | $1,870.62 | 2024-2025 | |
| Medinc of Texas | $1,315.62 | 2020-2022 | |
| Canon Medical Systems USA, INC. | $119.88 | 2019 | |
| Stryker Corporation | $118.00 | 2019-2025 | Augment Injectable |
| Abbott Laboratories | $98.75 | 2019 | |
| Depuy Synthes Sales INC. | $96.89 | 2019-2022 | |
| Mallinckrodt Enterprises LLC | $39.46 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $37.80 | 2019-2025 | Exparel |
| Pacira Therapeutics, INC. | $35.08 | 2019-2021 | |
| Bioventus LLC | $28.07 | 2022 | |
| Sanofi-Aventis U.S. LLC | $27.53 | 2019-2020 | |
| Anika Therapeutics, INC. | $23.21 | 2024 | Integrity, Tactoset, Atlas |
| Innovation Technologies INC | $17.73 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $14.89 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Murray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.